Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
106.43
Dollar change
+0.03
Percentage change
0.03
%
Index- P/E- EPS (ttm)-1.03 Insider Own8.93% Shs Outstand85.99M Perf Week0.11%
Market Cap9.15B Forward P/E88.80 EPS next Y1.20 Insider Trans-34.81% Shs Float78.31M Perf Month1.17%
Enterprise Value8.96B PEG- EPS next Q0.18 Inst Own81.51% Short Float2.57% Perf Quarter15.07%
Income-81.24M P/S41.06 EPS this Y179.84% Inst Trans-1.96% Short Ratio0.59 Perf Half Y62.84%
Sales222.90M P/B32.89 EPS next Y455.96% ROA-16.13% Short Interest2.01M Perf YTD129.18%
Book/sh3.24 P/C20.89 EPS next 5Y- ROE-36.38% 52W High106.44 -0.01% Perf Year279.56%
Cash/sh5.09 P/FCF- EPS past 3/5Y-31.33% 7.21% ROIC-15.57% 52W Low27.54 286.46% Perf 3Y922.38%
Dividend Est.- EV/EBITDA- Sales past 3/5Y1.88% - Gross Margin94.65% Volatility0.15% 0.23% Perf 5Y1524.89%
Dividend TTM- EV/Sales40.19 EPS Y/Y TTM34.29% Oper. Margin-25.19% ATR (14)0.37 Perf 10Y-
Dividend Ex-Date- Quick Ratio10.54 Sales Y/Y TTM1131.31% Profit Margin-36.44% RSI (14)73.36 Recom2.83
Dividend Gr. 3/5Y- - Current Ratio10.71 EPS Q/Q115.16% SMA200.46% Beta0.06 Target Price106.30
Payout- Debt/Eq0.88 Sales Q/Q- SMA501.84% Rel Volume0.27 Prev Close106.40
Employees209 LT Debt/Eq0.87 EarningsJul 31 SMA20045.14% Avg Volume3.42M Price106.43
IPOApr 27, 2017 Option/ShortYes / Yes EPS/Sales Surpr.7.93% 1.77% Trades Volume918,694 Change0.03%
Date Action Analyst Rating Change Price Target Change
Jul-14-25Downgrade H.C. Wainwright Buy → Neutral
Jul-01-25Initiated Wolfe Research Outperform $170
Apr-28-25Initiated TD Cowen Buy $100
Apr-21-25Initiated Cantor Fitzgerald Overweight $80
Jan-10-25Initiated ROTH MKM Buy $68
Oct-03-24Initiated Wells Fargo Overweight $50
May-22-23Resumed Jefferies Buy $35 → $38
Sep-19-22Resumed Wedbush Outperform $27
Aug-26-22Initiated Piper Sandler Overweight $31
Sep-13-21Initiated H.C. Wainwright Buy $25
Sep-12-25 08:12AM
Sep-11-25 10:05AM
Aug-28-25 11:49PM
Aug-12-25 12:00PM
Aug-11-25 11:32AM
09:17AM Loading…
09:17AM
Jul-31-25 08:39AM
Jul-30-25 10:08AM
08:47AM
Jul-29-25 04:17PM
12:10PM
Jul-28-25 04:30PM
Jul-25-25 08:27AM
Jul-22-25 09:33AM
Jul-21-25 11:16AM
03:54PM Loading…
Jul-17-25 03:54PM
11:34AM
08:15AM
Jul-16-25 10:07AM
Jul-15-25 02:04PM
12:00PM
08:32AM
08:28AM
Jul-14-25 11:24PM
10:23AM
08:51AM
01:30AM
Jul-13-25 07:01AM
Jul-12-25 02:34PM
Jul-11-25 10:41AM
08:19AM Loading…
08:19AM
Jul-10-25 10:17AM
08:50AM
06:59AM
04:04AM
12:39AM
Jul-09-25 05:03PM
04:11PM
01:19PM
01:15PM
11:56AM
10:36AM
10:11AM
09:59AM
09:46AM
09:34AM
09:19AM
09:05AM
08:05AM
07:48AM
07:48AM
07:28AM
07:14AM
06:30AM
01:09AM
Jul-08-25 10:54AM
10:38AM
Jul-07-25 10:00AM
06:21AM
Jul-03-25 10:32AM
08:42AM
Jul-02-25 10:32AM
09:55AM
09:28AM
Jul-01-25 10:50AM
08:50AM
Jun-24-25 01:08PM
10:15AM
Jun-13-25 02:12PM
Jun-05-25 11:22AM
May-29-25 04:25PM
May-27-25 08:06PM
May-23-25 06:19AM
May-21-25 06:00AM
May-13-25 11:11AM
May-08-25 10:54AM
May-06-25 05:55PM
06:00AM
May-01-25 08:51AM
Apr-30-25 08:38PM
03:12AM
Apr-29-25 03:45PM
06:00AM
Apr-28-25 07:26PM
Apr-23-25 05:48PM
02:58PM
Apr-19-25 05:30AM
Apr-17-25 04:53AM
Apr-15-25 06:00AM
Apr-07-25 10:47AM
Mar-30-25 03:00AM
Mar-28-25 08:00AM
07:00AM
Mar-27-25 10:40PM
Mar-26-25 03:48PM
Mar-14-25 10:34AM
Mar-05-25 08:20AM
Feb-28-25 02:18AM
Feb-27-25 06:00AM
Feb-26-25 07:15AM
Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cunningham KennethDirectorAug 01 '25Option Exercise0.0024,000090,584Aug 05 08:32 PM
Cunningham KennethDirectorAug 01 '25Sale13.1410,808142,05779,776Aug 05 08:32 PM
Deschamps LisaDirectorAug 01 '25Option Exercise0.0024,000094,320Aug 05 08:31 PM
Deschamps LisaDirectorAug 01 '25Sale13.149,464124,39284,856Aug 05 08:31 PM
Fisher AndrewGeneral CounselAug 01 '25Option Exercise0.0020,8880427,487Aug 05 08:30 PM
Fisher AndrewGeneral CounselAug 01 '25Sale13.149,584125,969417,903Aug 05 08:30 PM
Hahn Mark WChief Financial OfficerAug 01 '25Option Exercise0.00255,696012,673,880Aug 05 08:28 PM
Hahn Mark WChief Financial OfficerAug 01 '25Sale13.14208,9122,745,87712,464,968Aug 05 08:28 PM
Rickard Kathleen A.Chief Medical OfficerAug 01 '25Option Exercise0.0070,88802,665,808Aug 05 08:27 PM
Rickard Kathleen A.Chief Medical OfficerAug 01 '25Sale13.1458,336766,7512,607,472Aug 05 08:27 PM
ACKERMANN CHRISTINADirectorAug 01 '25Option Exercise0.0024,000065,880Aug 05 08:26 PM
ACKERMANN CHRISTINADirectorAug 01 '25Sale13.141,80823,76464,072Aug 05 08:26 PM
Austwick MichaelDirectorAug 01 '25Option Exercise0.0024,000024,000Aug 05 08:25 PM
Austwick MichaelDirectorAug 01 '25Sale13.1411,288148,36612,712Aug 05 08:25 PM
Brady James AloysiusDirectorAug 01 '25Option Exercise0.0024,000024,000Aug 05 08:24 PM
Brady James AloysiusDirectorAug 01 '25Sale13.1482410,83023,176Aug 05 08:24 PM
ZACCARDELLI DAVIDPresident and CEOAug 01 '25Option Exercise0.00255,696013,585,056Aug 05 08:22 PM
ZACCARDELLI DAVIDPresident and CEOAug 01 '25Sale13.14208,9122,745,87713,376,144Aug 05 08:22 PM
EBSWORTH DAVID RDirectorAug 01 '25Option Exercise0.0024,0000882,403Aug 05 08:21 PM
EBSWORTH DAVID RDirectorAug 01 '25Sale13.141,90425,026880,499Aug 05 08:21 PM
Edwards MartinDirectorAug 01 '25Option Exercise0.0024,0000168,800Aug 05 08:20 PM
Edwards MartinDirectorAug 01 '25Sale13.1410,808142,057157,992Aug 05 08:20 PM
SHAH MAHENDRADirectorAug 01 '25Option Exercise0.0024,000097,080Aug 05 08:18 PM
SHAH MAHENDRADirectorAug 01 '25Sale13.143,60847,42293,472Aug 05 08:18 PM
Sinha VikasDirectorAug 01 '25Option Exercise0.0024,000098,440Aug 05 08:17 PM
Sinha VikasDirectorAug 01 '25Sale13.144,32856,88694,112Aug 05 08:17 PM
Ullman AndersDirectorAug 01 '25Option Exercise0.0024,0000358,856Aug 05 08:16 PM
Hahn Mark WChief Financial OfficerJul 07 '25Option Exercise0.00229,512012,508,504Jul 09 06:41 PM
Rickard Kathleen A.Chief Medical OfficerJul 07 '25Option Exercise0.0086,06402,632,536Jul 09 06:39 PM
Fisher AndrewGeneral CounselJul 07 '25Option Exercise0.0086,0640446,063Jul 09 06:38 PM
ZACCARDELLI DAVIDPresident and CEOJul 07 '25Option Exercise0.00229,512013,419,680Jul 09 06:37 PM
Fisher AndrewGeneral CounselJun 16 '25Option Exercise2.0180,000160,904439,999Jun 18 04:31 PM
Fisher AndrewGeneral CounselJun 16 '25Sale11.5380,000922,000359,999Jun 18 04:31 PM
Hahn Mark WChief Financial OfficerJun 11 '25Sale11.40400,0004,560,36012,278,992Jun 13 04:31 PM
ZACCARDELLI DAVIDPresident and CEOJun 11 '25Sale11.40400,0004,560,52013,190,168Jun 13 04:30 PM
DAVID ZACCARDELLIDirectorJun 11 '25Proposed Sale86.7850,0004,339,000Jun 11 04:27 PM
MARK HAHNOfficerJun 11 '25Proposed Sale86.7850,0004,339,000Jun 11 04:26 PM
Hahn Mark WChief Financial OfficerMay 29 '25Sale9.33204,8641,911,66812,678,992May 29 04:16 PM
Hahn Mark WChief Financial OfficerMay 28 '25Sale9.30162,7041,513,29412,883,856May 29 04:16 PM
Hahn Mark WChief Financial OfficerMay 27 '25Sale9.5332,432308,98313,046,560May 29 04:16 PM
ZACCARDELLI DAVIDPresident and CEOMay 29 '25Sale9.33208,6961,947,59313,590,168May 29 04:15 PM
ZACCARDELLI DAVIDPresident and CEOMay 28 '25Sale9.30157,7041,466,80513,798,864May 29 04:15 PM
ZACCARDELLI DAVIDPresident and CEOMay 27 '25Sale9.5333,600320,18113,956,568May 29 04:15 PM
DAVID ZACCARDELLIDirectorMay 27 '25Proposed Sale75.0650,0003,753,000May 27 04:33 PM
MARK HAHNOfficerMay 27 '25Proposed Sale75.0650,0003,753,000May 27 04:31 PM
Sinha VikasDirectorMay 20 '25Option Exercise0.50160,00080,608234,440May 22 04:06 PM
Sinha VikasDirectorMay 20 '25Sale9.39160,0001,502,92874,440May 22 04:06 PM
VIKAS SINHADirectorMay 20 '25Proposed Sale72.5820,0001,451,600May 20 04:30 PM
Fisher AndrewGeneral CounselMay 15 '25Option Exercise2.1180,000169,040439,999May 16 04:31 PM
Fisher AndrewGeneral CounselMay 15 '25Sale8.5780,000685,600359,999May 16 04:31 PM
ACKERMANN CHRISTINADirectorMay 14 '25Option Exercise1.9340,00077,35281,880May 16 04:30 PM
ACKERMANN CHRISTINADirectorMay 14 '25Sale8.4440,000337,60041,880May 16 04:30 PM
ANDREW FISHEROfficerMay 15 '25Proposed Sale67.2430,0002,017,200May 15 04:25 PM
CHRISTINA ACKERMANNDirectorMay 14 '25Proposed Sale67.575,000337,850May 14 04:32 PM
Rickard Kathleen A.Chief Medical OfficerMay 06 '25Sale8.82114,9841,014,3432,546,472May 08 04:30 PM
KATHLEEN RICKARDOfficerMay 06 '25Proposed Sale72.2514,3731,038,449May 06 04:33 PM
Rickard Kathleen A.Chief Medical OfficerMay 01 '25Sale8.9549,200440,3502,633,320May 05 04:32 PM
Hahn Mark WChief Financial OfficerMay 02 '25Sale9.09400,0003,637,72013,078,992May 05 04:31 PM
Hahn Mark WChief Financial OfficerMay 01 '25Sale8.95187,0081,673,75913,357,728May 05 04:31 PM
EBSWORTH DAVID RDirectorMay 01 '25Option Exercise1.93140,000270,7321,476,003May 05 04:30 PM
ZACCARDELLI DAVIDPresident and CEOMay 02 '25Sale9.09400,0003,637,52013,990,168May 05 04:30 PM
ZACCARDELLI DAVIDPresident and CEOMay 01 '25Sale8.95187,0081,673,75914,268,904May 05 04:30 PM
MARK HAHNOfficerMay 02 '25Proposed Sale72.2650,0003,613,000May 02 04:24 PM
DAVID ZACCARDELLIDirectorMay 02 '25Proposed Sale72.2650,0003,613,000May 02 04:24 PM
Fisher AndrewGeneral CounselApr 29 '25Option Exercise0.0086,0640386,065May 01 08:59 PM
Fisher AndrewGeneral CounselApr 29 '25Sale8.9826,072234,127359,993May 01 08:59 PM
ZACCARDELLI DAVIDPresident and CEOApr 29 '25Option Exercise0.00229,512014,467,536May 01 08:58 PM
ZACCARDELLI DAVIDPresident and CEOApr 29 '25Sale8.9890,360811,43314,377,176May 01 08:58 PM
Rickard Kathleen A.Chief Medical OfficerApr 29 '25Option Exercise0.0086,06402,695,040May 01 08:56 PM
Rickard Kathleen A.Chief Medical OfficerApr 29 '25Sale8.9834,384308,7682,660,656May 01 08:56 PM
Hahn Mark WChief Financial OfficerApr 29 '25Option Exercise0.00229,512013,556,360May 01 08:55 PM
Hahn Mark WChief Financial OfficerApr 29 '25Sale8.9890,360811,43313,466,000May 01 08:55 PM
Sinha VikasDirectorApr 29 '25Option Exercise1.4020,00028,07689,488May 01 08:53 PM
Sinha VikasDirectorApr 29 '25Sale8.9220,000178,41674,440May 01 08:53 PM
VIKAS SINHADirectorApr 29 '25Proposed Sale68.8320,0001,376,600Apr 29 04:21 PM
Rickard Kathleen A.Chief Medical OfficerMar 12 '25Sale8.3579,264661,9422,608,976Mar 13 08:15 PM
KATHLEEN RICKARDOfficerMar 12 '25Proposed Sale62.709,908621,232Mar 12 04:23 PM
EBSWORTH DAVID RDirectorFeb 26 '25Option Exercise1.30460,000600,0601,400,003Feb 28 04:30 PM
ZACCARDELLI DAVIDPresident and CEODec 05 '24Sale5.01640,2643,205,22614,367,552Dec 06 05:51 PM
ZACCARDELLI DAVIDPresident and CEODec 06 '24Sale5.01162,800815,40014,204,752Dec 06 05:51 PM
ZACCARDELLI DAVIDPresident and CEODec 04 '24Sale5.0067,608338,16215,007,816Dec 06 05:51 PM
Hahn Mark WChief Financial OfficerDec 05 '24Sale5.01640,0483,204,14413,477,464Dec 06 05:50 PM
Hahn Mark WChief Financial OfficerDec 06 '24Sale5.01183,728920,31213,293,736Dec 06 05:50 PM
Hahn Mark WChief Financial OfficerDec 04 '24Sale5.0058,184290,99614,117,512Dec 06 05:50 PM
Hahn Mark WChief Financial OfficerNov 29 '24Sale5.0198,704494,14214,177,296Dec 02 07:20 PM
Hahn Mark WChief Financial OfficerNov 27 '24Sale5.0012,93664,68014,276,000Dec 02 07:20 PM
Hahn Mark WChief Financial OfficerDec 02 '24Sale5.001,6008,00014,175,696Dec 02 07:20 PM
ZACCARDELLI DAVIDPresident and CEONov 29 '24Sale5.0198,888495,03315,078,624Dec 02 07:19 PM
ZACCARDELLI DAVIDPresident and CEONov 27 '24Sale5.0023,240116,20015,177,512Dec 02 07:19 PM
ZACCARDELLI DAVIDPresident and CEODec 02 '24Sale5.003,20016,00015,075,424Dec 02 07:19 PM
Hahn Mark WChief Financial OfficerNov 25 '24Sale5.001,6008,00014,289,736Nov 26 06:36 PM
Hahn Mark WChief Financial OfficerNov 26 '24Sale5.008004,00014,288,936Nov 26 06:36 PM
ZACCARDELLI DAVIDPresident and CEONov 25 '24Sale5.001,6008,00015,200,752Nov 26 06:35 PM
Rickard Kathleen A.Chief Medical OfficerNov 25 '24Sale4.90240,0001,176,3602,671,480Nov 26 06:34 PM
KATHLEEN A RICKARDOfficerNov 25 '24Proposed Sale39.2130,0001,176,357Nov 25 04:42 PM
EBSWORTH DAVID RDirectorNov 18 '24Buy4.4420,00088,800940,003Nov 18 04:20 PM
ZACCARDELLI DAVIDPresident and CEONov 11 '24Sale5.002,40012,00015,202,352Nov 13 04:58 PM
Hahn Mark WChief Financial OfficerNov 11 '24Sale5.002,40012,00014,291,336Nov 13 04:57 PM
MARK HAHN OfficerNov 11 '24Proposed Sale38.58125,0004,822,500Nov 12 07:55 AM
EBSWORTH DAVID RDirectorNov 06 '24Buy4.8039,360188,881920,003Nov 07 06:57 PM